AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AbbVie Inc. Director's Dealing 2014

Dec 22, 2014

29755_dirs_2014-12-22_cec00d3a-42c8-434f-b91d-d919362e3981.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2014-12-22

Reporting Person: CHASE WILLIAM J (EVP, Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-12-22	Common stock, $0.01 par value	M	8495	$24.0731	Acquired	188563	Direct
2014-12-22	Common stock, $0.01 par value	S	8495	$68.00	Disposed	180068	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-12-22	Option (right to buy)	$24.0731	M	8495	Disposed	2015-02-17	Common stock (8495)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock, $0.01 par value	501	Indirect

Footnotes

F1: Held by spouse in the AbbVie Savings Program as of December 18, 2014. The reporting person disclaims beneficial ownership of all securities held by his spouse.